Keppra is an effective solution for the treatment of partial seizures. It has an active component, Levetiracetam. It is manufactured by one of the leading pharmaceutical companies, Ucb Inc. it is available for oral consumption as a conventional tablet in dosages 250 mg, 500 mg, 750 mg, and 1000 mg.
Manufacturer: Ucb Inc
Active Ingredient: Levetiracetam is an active ingredient in this medication. This medication is a pyrrolidine with antiepileptic activity. It acts as exerting its effects and does not involve inhibitory and excitatory neurotransmitter activity. Stereoselective binding of this active component was confined to synaptic plasma membranes in the central nervous system in peripheral tissue. It inhibits burst firing without affecting normal neuronal excitability that it may selectively prevent hyper-synchronization of epileptiform burst firing and propagation of seizure activity.
Indications: This mentioned medication is an anti-epileptic drug, which is also known as an anticonvulsant. This medicine is indicated for the treatment of partial-onset seizures in adults and children who are at least 1 month old. This effective medication is a unique anticonvulsant that is typically prescribed in combination with other antiepileptic medications for partial-onset seizures. Keppra is used in treatment-induced liver disease.
Action Mechanism: The action mechanism of this medicine is not known but scientists believed that Keppra inhibits the spread of seizure activity in the brain. Additionally, this antiseizure drug reduced the frequency of seizures more than the placebo.
Dosages: This antiseizure medicine is available in the following dosages:
- 250 mg: This medication should be taken once a day as directed by the doctor
- 500 mg: It is to be consumed once a day with or without food as mentioned in the prescription by the doctor
- 750 mg: Administer this drug as advised by the doctor, do not go against it
- 1000 mg: Consume this tablet as per the instruction by the doctor, usually once in a day
Note: This medication is also indicated to treat tonic-clonic seizures in people above 6 years old, and myoclonic seizures in people above 12 years old